News

Dermacyte Oxygen Concentrate is the first product in a broad and diverse cosmetic line currently under development at Oxygen Biotherapeutics. It uses the company’s patented Oxycyte technology, an

Mr Wieland has over 30 years of senior financial experience with US-based public and private companies. He has served as the CFO of four NASDAQ-listed companies within the

Breckenridge Pharma is a pharmaceutical marketing, research and development company founded in 1983 that markets a range of generic prescription products in many therapeutic categories including several ValuBrand

According to Eisai, the arrangement covers the development of a combination antiemetic agent (in both oral and intravenous forms) containing netupitant (generic name), a neurokinin-1 (NK1) receptor antagonist,

Sucampo claimed that the trial met its primary endpoint with statistical significance and demonstrated a safety profile consistent with previously reported clinical lubiprostone data. The primary endpoint of

The trial is designed as a double-blind, placebo controlled, randomised, cross-over study comprising up to 60 non-smoking patients with moderate to severe COPD (GOLD II-III). Revotar said that

The expanded agreement solidifies Patheon as a preferred supplier to Merck. Patheon’s projects and services are expected to be delivered to Merck from eight of its global facilities.

Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.

Excellagen is a fibrillar bovine Type I collagen-based topical gel (2.6% collagen concentration) that is formulated to include structural stabilizers, hydrolytic enzyme inhibitors, and bacteriostatic agents. Cardium said